Kinase insert domain receptor
From Wikipedia, the free encyclopedia
| edit |
Kinase insert domain receptor (a type III receptor tyrosine kinase) is a VEGF receptor. KDR is the human gene encoding it. KDR has also been designated as CD309 (cluster of differentiation 309). Flk1 is the abbreviation for fetal liver kinase 1.
Contents |
[edit] Interactions
Kinase insert domain receptor has been shown to interact with SHC2,[1] Annexin A5[2] and SHC1.[3][4]
[edit] See also
[edit] Further reading
- Petrova TV, Makinen T, Alitalo K (1999). "Signaling via vascular endothelial growth factor receptors.". Exp. Cell Res. 253 (1): 117–30. doi:. PMID 10579917.
- Sato Y, Kanno S, Oda N, et al. (2000). "Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.". Ann. N. Y. Acad. Sci. 902: 201–5; discussion 205–7. PMID 10865839.
- Zachary I, Gliki G (2001). "Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.". Cardiovasc. Res. 49 (3): 568–81. doi:. PMID 11166270.
- Vené R, Benelli R, Noonan DM, Albini A (2001). "HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis.". Clin. Exp. Metastasis 18 (7): 533–8. doi:. PMID 11688957.
- Lenton K (2003). "VEGFR-2 (KDR/Flk-1).". J. Biol. Regul. Homeost. Agents 16 (3): 227–32. PMID 12456025.
- Matsumoto T, Mugishima H (2006). "Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis.". J. Atheroscler. Thromb. 13 (3): 130–5. PMID 16835467.
|
|||||
[edit] References
- ^ Warner, A J; Lopez-Dee J, Knight E L, Feramisco J R, Prigent S A (Apr. 2000). "The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells". Biochem. J. (England) 347 (Pt 2): 501-9. ISSN 0264-6021. PMID 10749680.
- ^ Wen, Y; Edelman J L, Kang T, Sachs G (May. 1999). "Lipocortin V may function as a signaling protein for vascular endothelial growth factor receptor-2/Flk-1". Biochem. Biophys. Res. Commun. (UNITED STATES) 258 (3): 713-21. doi:. ISSN 0006-291X. PMID 10329451.
- ^ Zanetti, Adriana; Lampugnani Maria Grazia, Balconi Giovanna, Breviario Ferruccio, Corada Monica, Lanfrancone Luisa, Dejana Elisabetta (Apr. 2002). "Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling". Arterioscler. Thromb. Vasc. Biol. (United States) 22 (4): 617-22. PMID 11950700.
- ^ D'Angelo, G; Martini J F, Iiri T, Fantl W J, Martial J, Weiner R I (May. 1999). "16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells". Mol. Endocrinol. (UNITED STATES) 13 (5): 692-704. ISSN 0888-8809. PMID 10319320.
[edit] External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||
|
||||||||||||||||||||
| This transmembrane receptor-related article is a stub. You can help Wikipedia by expanding it. |